CLVS

CLVS Articles

This past week is being touted as the best week of the S&P 500 for 2015, but the love was not universally shared among all stocks.
Tuesday's top analyst upgrades, downgrades and initiations include Antero Resources, Athenahealth, Capstone Turbine, Clovis Oncology, Genworth Financial, Merck, Nuance Communications and...
Clovis Oncology was leading the bears in Monday’s trading session on news that its lung cancer drug may be delayed.
Over the past week, a few biotech companies made absolutely massive runs with at least 25% gains.
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of August and added some color.
Monday's top analyst upgrades, downgrades and initiations include Amazon.com, Clovis Oncology, Glaukos, Hertz Global, Peabody Energy and Whiting Petroleum.
Friday's top analyst upgrades, downgrades and initiations include Apple, Clovis Oncology, Deere, JC Penney, Wynn Resorts and Yum! Brands.
Monday's top analyst upgrades, downgrades and initiations include Apple, BP, Hewlett-Packard, Philip Morris, UnitedHealth and AT&T.
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, March 24, 2014. They include Bank of America, NetApp, Stratasys, Symantec and Wells...
Biotechnology was an incredible performer in 2013. The analysts at J.P. Morgan think that the huge outperformance may lessen going forward but can stay intact. They think the fundamental backdrop is...
The stock market is down Monday, with the Dow Jones Industrial Average down 0.08%, the Nasdaq down 0.02% and the S&P 500 down 0.01%. Today’s winners include two companies getting bought out and...
Shortly after noon ET today, all three major US stock indexes have posted solid gains, with the DJIA up about 54 points at around12,892, the Nasdaq up about 27 points at 2,963, and the S&P 500 up...
IPO Fever has not really caught on in a major way yet in 2012.  The Facebook halo-effect did bring a pop and private equity firms are still seeming to hold up.  We already picked out the Top 17...